Stocks
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -193.3 | -175.2 | -189.3 | -128.8 | -29.8 | -22.0 | ||
| Changes by years, y/y, % | +34% | -9% | +8% | -32% | -77% | -27.0% | |||
Adaptive Biotechnologies. EBITDA US GAAP, bln rub
Adaptive Biotechnologies. EBITDA US GAAP, changes, %
Adaptive Biotechnologies. EBITDA US GAAP, sum by quarters, bln rub
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -29.6 | -18.1 | 16.9 | -6.43 | -14.4 | -22.0 | |
| Changes by years, y/y, % | -25% | -53% | -169% | -76% | -51% | |||
| Changes by quarters, q/q, % | +12% | -39% | -193% | -138% | +124% | |||
